Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Insulin Pump Market is Projected to Reach US$ 9.7 Bn at a CAGR of 10.3% by year 2032-end, Amid Steady Increase in Diabetes Incidence, and a Surge in Prevalence of Obesity | Future Market Insights, Inc.
By: PR Newswire Association LLC. - 23 Nov 2022Back to overview list

Tethered Pumps to Dominate the Insulin Pumps Demand throughout the Analysis Period with over 3/4th Revenue Share. US dominated North America Insulin Pump market and poised to reach US$ 3.6 Bn by 2032. Japan Insulin Pump Market is likely to reach US$ 781 Mn by 2032, growing at a CAGR of 13% during 2022 – 2032

NEWARK, Del., Nov. 23, 2022 /PRNewswire/ -- The Insulin Pumps Market revenues were estimated at US$ 5.5 Bn in 2022 and is anticipated to grow at a CAGR of 10.3% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 14.8 Mn. The demand for tethered pumps is projected to garner an absolute dollar opportunity of US$ 6.7 Bn during 2022 – 2032.

FMI_Logo

One of the reasons driving market expansion is an increase in the incidence of diabetes owing to age, obesity, and an unhealthy lifestyle. Obesity is a primary cause of diabetes, which leads to a rise in the prevalence of diabetes-related ocular illnesses. In 2017, the worldwide incidence of diabetes was estimated to be about 22.9 million, the prevalence was reported to be around 476 million, 1.37 million fatalities were recorded owing to diabetes, and 1.37 million disability-adjusted life-years (DALYs) were reported to be related to diabetes. According to the WHO, over 1.9 billion individuals were overweight in 2017, with around 650 million people classed as obese.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15803

Obesity and being overweight are risk factors that are increasing the occurrence of type II diabetes. As a result, risk factors such as smoking, being overweight, being obese, and having high cholesterol are likely to increase the prevalence of type II diabetes.

Competitive Landscape

Over the projected period, rising emphasis on innovations and investments among public and private entities is expected to strengthen competition in the market. In addition, product commercialization and partnership tactics are expected to be profitable in the upcoming years.

The key vendors in the global Insulin Pump market are Cellenovo, Sooil Development, Valeritas, Inc, JingasuDelfu Co., Ltd., Medtronic plc, Hoffmann-La Roche Ltd, Tandem Diabetic Care, Inc., Insulet Corporation, and Ypsomed.

Some of the recent developments in Insulin Pump market are:

  • In June 2019, Medtronic announced a partnership with Tidepool to develop an interoperable automated insulin pump system. The Medtronic MiniMed pump will serve as one of Tidepool Loop's accessories, designed to communicate with Apple devices.
  • In September 2020, Insulet Corporation, stated that its Omnipod DASH Insulin Management System would be widely available in Israel, Switzerland, Austria, Germany, Belgium, and France in the coming weeks. Denmark, Norway, Finland, and Sweden have already exposure to this product.
  • In June 2020, Tandem Diabetes Care and Abbott announced a collaboration to develop and commercialize integrated diabetes care solutions. These products will combine Abbott's continuous glucose monitoring technology with Tandem's ground-breaking insulin delivery devices to better diabetic blood sugar control.
  • In September 2020, Medtronic announced that their MiniMedTM 770G hybrid closed loop system has received FDA clearance in the United States. This unique insulin administration system, which is equipped with the company's SmartGuard technology, and can be connected to a smartphone and can be modified for youngsters as young as two years old.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15803

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Insulin Pump market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Type (Patch Pumps, Tethered Pumps), Product Type (Tandem (T: slim X2, G4, T: flex Delivery System), Accu-Chek (Combo, Insight, and Solo), MiniMed (630G, 670G, and VEO), Omnipod, My Life Omnipod and Other Product Types), Accessories (Insulin reservoir or cartridges, Insulin set insertion devices and Battery) Across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

About Future Market Insights (FMI)

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Market Segments Covered in Insulin Pump Industry Analysis

By Type:

  • Patch Pumps
  • Tethered Pumps

By Product Type:

  • Tandem
  • Accu-Chek
  • MiniMed
  • Omnipod
  • My Life Omnipod
  • Other Product Types

By Accessories:

  • Insulin reservoir or cartridges
  • Insulin set insertion devices
  • Battery

By End-User:

  • Homecare
  • Hospitals & clinics
  • Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

For More Information@ https://www.futuremarketinsights.com/reports/insulin-pumps-market

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage

    2.2. Market Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

Request a Methodology @ https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15803

Explore Wide-ranging Coverage of FMI's Healthcare Landscape

U.S. Animal Model Market Size : is set to increase at a 4.1% CAGR from 2022 to 2032, with the market valuation reaching around US$ 947.3 Mn in 2022.

Research Antibodies Market Share : is US$ 4.1 Billion, which is projected to increase by 7.3% to reach US$ 4.3 Billion market by the end of 2022.

Weight Management Market Demand : is expected to garner US$ 725.6 Billion during the forecast period from 2022 to 2032. 

IV Infusion Gravity Bags Market Growth : garnered a market value of US$ 723.8 Million in 2022 and is expected to accumulate a market value of US$ 1281.3 Million by registering a CAGR of 5.87% in the forecast period 2022-2032.

Laryngeal Mask Market Outlook : is projected to grow at a CAGR of over 7.9% during 2022 – 2032.

Cancer Gene Therapy Market Trends : is expected to increase at a 10.1% CAGR from 2022 to 2032, reaching US$ 2 Bn in 2022. 

Medical Device Analytical Testing Outsourcing Market Scope : garnered US$ 5.11 Billion in 2021, and is credibly to exhibit a CAGR of 7.18% surpassing a valuation of US$ 10.96 Billion in 2032.

Oxygen Therapy Equipment Market Analysis : is anticipated to reflect a CAGR of 7.4% during the period of 2022-2032. The Oxygen Therapy Equipment Market is anticipated to reach US$ 6.4 Billion in 2032, from US$ 3.1 Billion in 2022.

Patient Positioning System Market Technology : is expected to garner a notable market value of US$ 1.8 Billion in 2032, as opposed to US$ 1.25 Billion in 2022.

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware - 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

Logo: https://mma.prnewswire.com/media/1197648/FMI_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/insulin-pump-market-is-projected-to-reach-us-9-7-bn-at-a-cagr-of-10-3-by-year-2032-end-amid-steady-increase-in-diabetes-incidence-and-a-surge-in-prevalence-of-obesity--future-market-insights-inc-301686047.html

SOURCE Future Market Insights

Copyright 2022 PR Newswire Association LLC. Back to overview list
to the top ↑